William Roberts, VP Regulatory Development and at REGENERON PHARMACEUTICALS INC (REGN), sold 28,404 shares at $62.76 ($1.9M) on 2011-09-06, disclosed to the SEC on 2011-09-08.
Scheduled sale ($1.9M) by VP Regulatory Development and under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.76 | 300 | $19K | 1.0% |
| 2 | $63.52 | 200 | $13K | 0.7% |
| 3 | $64.43 | 700 | $45K | 2.4% |
| 4 | $65.76 | 1,580 | $104K | 5.5% |
| 5 | $65.76 | 1,716 | $113K | 5.9% |
| 6 | $65.76 | 798 |
| $52K |
| 2.8% |
| 7 | $65.76 | 1,344 | $88K | 4.6% |
| 8 | $65.81 | 3,800 | $250K | 13.1% |
| 9 | $66.42 | 8,578 | $570K | 29.9% |
| 10 | $67.43 | 1,200 | $81K | 4.3% |
| 11 | $68.41 | 1,685 | $115K | 6.1% |
| 12 | $67.48 | 400 | $27K | 1.4% |
| 13 | $68.84 | 1,384 | $95K | 5.0% |
| 14 | $69.56 | 1,300 | $90K | 4.8% |
| 15 | $70.38 | 3,419 | $241K | 12.6% |
| Total | $67.02 avg | 28,404 | $1.9M | 100% |
| Filing → |
| REGN | SELL | 2012-08-27 | $2.2M | — | Filing → |
| REGN | SELL | 2012-01-11 | $2.4M | — | Filing → |
| REGN | SELL | 2011-07-18 | $6K | — | Filing → |